Have a feature idea you'd love to see implemented?
Let us know!
ENZ Enzo Biochem Inc
Price (delayed)
$0.7627
Market cap
$39.85M
P/E Ratio
N/A
Dividend/share
$0.1
EPS
-$0.45
Enterprise value
-$4.7M
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous
Highlights
Enzo Biochem's debt has shrunk by 54% YoY and by 7% QoQ
Enzo Biochem's net income has plunged by 194% YoY but it has increased by 12% from the previous quarter
The EPS has plunged by 190% YoY but it has grown by 12% from the previous quarter
ENZ's equity is down by 36% YoY and by 15% from the previous quarter
Enzo Biochem's quick ratio has decreased by 13% YoY and by 11% from the previous quarter
Key stats
What are the main financial stats of ENZ
Market
Valuations
Earnings
Shares outstanding
52.24M
Market cap
$39.85M
Enterprise value
-$4.7M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.84
Price to sales (P/S)
1.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.15
Revenue
$30.31M
Gross profit
$13.46M
Net income
-$22.84M
EBIT
-$22.29M
EBITDA
-$20.96M
Free cash flow
-$22.61M
Per share
Balance sheet
Liquidity
EPS
-$0.45
EPS diluted
-$0.45
Free cash flow per share
-$0.43
Book value per share
$0.91
Revenue per share
$0.58
TBVPS
$1.44
Total assets
$75.29M
Total liabilities
$27.63M
Debt
$3.19M
Equity
$47.66M
Working capital
$36.26M
Debt to equity
0.07
Current ratio
2.55
Quick ratio
2.2
Net debt/EBITDA
2.12
Margins
Efficiency
Dividend
EBITDA margin
-69.2%
Gross margin
44.4%
Net margin
-75.3%
Operating margin
-34.7%
Return on assets
-25.8%
Return on equity
-37.5%
Return on invested capital
-156.5%
Return on capital employed
-42.9%
Return on sales
-73.5%
Dividend yield
13.11%
DPS
$0.1
Payout ratio
N/A
ENZ stock price
How has the Enzo Biochem stock price performed over time
Intraday
7.05%
1 week
-25.23%
1 month
-22.73%
1 year
-46.66%
YTD
-45.13%
QTD
-31.9%
Financial performance
How have Enzo Biochem's revenue and profit performed over time
Revenue
$30.31M
Gross profit
$13.46M
Operating income
-$10.52M
Net income
-$22.84M
Gross margin
44.4%
Net margin
-75.3%
Enzo Biochem's net margin has shrunk by 198% YoY but it has increased by 8% QoQ
Enzo Biochem's net income has plunged by 194% YoY but it has increased by 12% from the previous quarter
The operating income has soared by 59% YoY and by 15% from the previous quarter
The operating margin has soared by 57% YoY and by 11% from the previous quarter
Growth
What is Enzo Biochem's growth rate over time
Valuation
What is Enzo Biochem stock price valuation
P/E
N/A
P/B
0.84
P/S
1.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.15
The EPS has plunged by 190% YoY but it has grown by 12% from the previous quarter
The P/B is 58% less than the 5-year quarterly average of 2.0 and 16% less than the last 4 quarters average of 1.0
ENZ's equity is down by 36% YoY and by 15% from the previous quarter
The P/S is 38% below the 5-year quarterly average of 2.1 and 27% below the last 4 quarters average of 1.8
The company's revenue fell by 5% QoQ and by 4.6% YoY
Efficiency
How efficient is Enzo Biochem business performance
ENZ's ROA has dropped by 200% year-on-year but it is up by 4.8% since the previous quarter
The ROS has plunged by 194% YoY but it has grown by 9% from the previous quarter
ENZ's ROE has shrunk by 179% YoY but it is up by 2.8% QoQ
The ROIC has grown by 2% from the previous quarter
Dividends
What is ENZ's dividend history
DPS
$0.1
Dividend yield
13.11%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Enzo Biochem financials performed over time
ENZ's total assets is 172% greater than its total liabilities
ENZ's total assets is down by 29% year-on-year and by 12% since the previous quarter
The current ratio has contracted by 16% YoY and by 10% from the previous quarter
Enzo Biochem's debt is 93% lower than its equity
Enzo Biochem's debt has shrunk by 54% YoY and by 7% QoQ
ENZ's equity is down by 36% YoY and by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.